<!DOCTYPE html>

<!--
  Created : 1/26/2012 2:00 PM
  Author : Tom Coleman
  Copyright : 2011-2011
  By : University of Missippi Medical Center
-->

<html>
<head>
<title> Model </title>
<link rel='stylesheet' type='text/css' href='../../Style.CSS'>
</head>

<body>

<img src='../../SmallTitle.PNG'>
<img src='../XMLLightBlue.png'>
<a href='Docs_Glucagon.html'><img src='../../Back.PNG'></a>
<p>
QHP 2008 / Glucagon.DOCS<br>
<br>
Created : 27-Mar-09<br>
Last Modified : 27-Mar-09<br>
Author : Tom Coleman<br>
Copyright : 2009<br>
<br>
&lt;structurename&gt; GlucagonSecretion &lt;/structurename&gt;<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt; GlucagonSecretion.Base &lt;/name&gt;<br>
&lt;topic&gt; Glucagon Secretion - Overview &lt;/topic&gt;<br>
&lt;topic&gt; Glucagon - Physical Units &lt;/topic&gt;<br>
&lt;topic&gt; Glucagon - Concentration Units &lt;/topic&gt;<br>
&lt;seealso&gt; GlucagonPool.[Glucagon] &lt;/seealso&gt;<br>
&lt;/vardoc&gt;<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt; GlucagonSecretion.GlucoseEffect &lt;/name&gt;<br>
&lt;topic&gt;  Glucose Effect - Overview &lt;/topic&gt;<br>
&lt;topic&gt; XXXX &lt;/topic&gt;<br>
&lt;topic&gt; XXX &lt;/topic&gt;<br>
&lt;seealso&gt; XXX &lt;/seealso&gt;<br>
&lt;seealso&gt; XXXX &lt;/seealso&gt;<br>
&lt;/vardoc&gt;<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt; GlucagonSecretion.InsulinEffect &lt;/name&gt;<br>
&lt;topic&gt; Insulin Effect - Overview &lt;/topic&gt;<br>
&lt;topic&gt; XXX &lt;/topic&gt;<br>
&lt;topic&gt; XXX &lt;/topic&gt;<br>
&lt;seealso&gt; XXXX &lt;/seealso&gt;<br>
&lt;seealso&gt; XXXX &lt;/seealso&gt;<br>
&lt;/vardoc&gt;<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt; GlucagonSecretion.Rate &lt;/name&gt;<br>
&lt;topic&gt; XX &lt;/topic&gt;<br>
&lt;topic&gt; XX &lt;/topic&gt;<br>
&lt;topic&gt; XXXX &lt;/topic&gt;<br>
&lt;seealso&gt; XXX &lt;/seealso&gt;<br>
&lt;seealso&gt; XXX &lt;/seealso&gt;<br>
&lt;/vardoc&gt;<br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt; Glucagon Secretion - Overview &lt;/name&gt;<br>
&lt;label&gt; Overview &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
Glucagon is an important regulator of glucose homeostasis.<br>
In short term studies glucose recovery from hypoglycemia <br>
was shown to be impaired by ~40% when the glucagon <br>
secretory response was suppressed.<br>
<br>
Rizza RA, Cryer PE, Gerich JE. Role of glucagon, <br>
epinephrine and growth hormone in human glucose <br>
counterregulation: effects of somatostatin and adrenergic <br>
blockade on plasma glucose recovery and glucose flux rates<br>
following insulin-induced hypoglycemia. <br>
J Clin Invest 64:62 - 71, 1979.<br>
 <br>
The physiological control of glucagon secretion however <br>
is not completely understood. The debate continues as to <br>
whether alpha cells directly sense and respond to <br>
fluctuations in plasma glucose or whether the response <br>
is mediated by the autonomic nervous system and/or the <br>
paracrine/endocrine effects of secretory products from <br>
other islet cells. Evidence suggests that intra-islet <br>
insulin, somatostatin and zinc respectively may play <br>
prominent roles for regulating glucagon release in <br>
response to hypoglycemia.<br>
<br>
In the model, glucagon secretion is controlled by <br>
plasma glucose and plasma insulin concentrations <br>
respectively. As plasma glucose levels decrease, glucagon <br>
secretion increases. As plasma insulin levels increase,<br>
glucagon secretion decreases. The model does not delineate<br>
the various mechanisms involved.<br>
<br>
Gromada J, Franklin I, Wollheim CB. Alpha cells of the<br>
endocrine pancreas: 35 years of research but the enigma<br>
remains. Endocrine Reviews 28: 84 - 116, 2007.<br>
<br>
Queseda I, Tuduri E, Ripoll C, Nadal A. Physiology of<br>
the pancreatic alpha and glucagon secretion: role in <br>
glucose homeostasis and diabetes. <br>
J of Endocrin 199: 5 -19, 2008.   <br>
<br>
Maruyama H, Hisatomi A, Orci L, Grodsky GM, Unger RH.<br>
Insulin within islets is a physiologic glucagon release<br>
inhibitor. J. Clin Invest 74: 2296 - 2299, 1984.<br>
<br>
Rutter GA. Regulating glucagon secretion: somatostatin<br>
in the spotlight. Diabetes 58: 299 - 301, 2009.<br>
<br>
Hauge-Evans AC, King AJ, Carmignac D, Richardson CC,<br>
Robinson ICAF, Low MJ, Christie MR, Persaud SJ, Jones PM.<br>
Somatostatin secreted by islet delta cells fulfills <br>
multiple roles as a paracrine regulator of islet function.<br>
Diabetes 58: 403-411, 2009. <br>
<br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt;<br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt; Glucagon - Physical Units &lt;/name&gt;<br>
&lt;label&gt; Physical Units &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
Plasma Concentration  pG/mL; pMol/L<br>
1 pG/mL = 0.282 pMol/L<br>
Mass  pG or nG<br>
Secretion nG/Min <br>
<br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt;<br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt; Glucagon - Concentration Units &lt;/name&gt;<br>
&lt;label&gt; Concentration Units &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
Molecular Weight (MW) of glucagon is 3550<br>
<br>
Typical plasma glucagon concentration [Glucagon] = 70 pG/mL<br>
The volume of distribution is the ECFV.<br>
<br>
Glucagon Mass = ECFV * [Glucagon]<br>
             = 15000 * 70 = 1,050,000 pG or 1,050 nG<br>
<br>
Typical glucagon concentrations under a variety of<br>
physiological situations<br>
<br>
<br>
Starve      300pG/mL    <br>
Fast        100pG/mL    <br>
Drip         70pG/mL       <br>
Meal         50pG/mL   <br>
Load         40pG/mL  <br>
<br>
Unger RH, Aguilar-Parada E, Muller WA, Eisentrant AM.<br>
Studies of pancreatic alpha cell function in normal<br>
and diabetic patients. J. Clin Invest. 49: 837-848, 1970 <br>
<br>
Felig P, Wahren J, Sherwin R, Hendler R. Insulin, glucagon,<br>
and somatostatin in normal physiology and diabetes mellitus   <br>
Diabetes 25: 1091 - 1099, 1976<br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt;<br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt; Glucose Effect &lt;/name&gt;<br>
&lt;label&gt; Glucose Effect - Overview &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
<br>
<br>
Using a stepped hypoglycemic clamp technique, the glucose<br>
threshold for glucagon release was 68 mG/mL<br>
<br>
Status [Glg] [Glu] Sec<br>
------ ----- ----- ----<br>
Max     350    50  260<br>
Starve  300    60<br>
Fast    100    85<br>
Drip     70   110   50<br>
Meal     50   130<br>
Load     40   200<br>
Min       0   400    0<br>
<br>
 <br>
Raskin P, Fujita Y, Unger RH. Effect of insulin-glucose infusions <br>
on plasma glucagon levels in fasting diabetics and nondiabetics.<br>
J Clin Invest 56: 1132 - 1138, 1975<br>
<br>
Ohneda A, Aguilar-Parada E, Eisentraut AM, Unger RH. Control of <br>
pancreatic glucagon secretion by glucose. Diabetes 18:1-10, 1969.<br>
<br>
Schwartz NS, Clutter WE, Shah SD, Cryer PE. Glycemic <br>
thresholds for activation of glucose counterregulatory<br>
systems are higher than the thresholds for symptoms.<br>
J Clin Invest. 79: 777 - 781, 1987.<br>
<br>
Cryer PE. Glucose Counterregulation: prevention and correction of<br>
hypoglycemia in humans. Am J Physiol 264: E149 - E155, 1993.<br>
<br>
<br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt;<br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt;  Insulin Effect - Overview &lt;/name&gt;<br>
&lt;label&gt;  Overview &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
<br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt;<br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt; XXX &lt;/name&gt;<br>
&lt;label&gt; XXX &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
<br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt;<br>
<br>
   <br>
<br>
End

<p><img src='../../Footer.PNG'>

</body>
</html>
